As of 2026-03-24, the Relative Valuation of Encompass Health Corp (EHC) is 138.82 USD. This relative valuation is based on P/E multiples. With the latest stock price at 97.52 USD, the upside of Encompass Health Corp based on Relative Valuation is 42.4%.
The range of the Relative Valuation is 119.71 - 150.46 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.0x - 26.4x | 23.0x |
| Forward P/E multiples | 18.0x - 18.6x | 18.2x |
| Fair Price | 119.71 - 150.46 | 138.82 |
| Upside | 22.8% - 54.3% | 42.4% |
| Date | P/E |
| 2026-03-20 | 16.83 |
| 2026-03-19 | 17.19 |
| 2026-03-18 | 17.50 |
| 2026-03-17 | 17.83 |
| 2026-03-16 | 17.81 |
| 2026-03-13 | 17.62 |
| 2026-03-12 | 17.61 |
| 2026-03-11 | 17.67 |
| 2026-03-10 | 18.77 |
| 2026-03-09 | 19.07 |
| 2026-03-06 | 18.78 |
| 2026-03-05 | 18.90 |
| 2026-03-04 | 19.13 |
| 2026-03-03 | 18.97 |
| 2026-03-02 | 18.97 |
| 2026-02-27 | 18.94 |
| 2026-02-26 | 18.82 |
| 2026-02-25 | 18.64 |
| 2026-02-24 | 18.41 |
| 2026-02-23 | 18.64 |
| 2026-02-20 | 18.71 |
| 2026-02-19 | 18.81 |
| 2026-02-18 | 19.15 |
| 2026-02-17 | 19.23 |
| 2026-02-13 | 19.34 |
| 2026-02-12 | 19.68 |
| 2026-02-11 | 19.92 |
| 2026-02-10 | 19.14 |
| 2026-02-09 | 18.64 |
| 2026-02-06 | 18.51 |
| 2026-02-05 | 17.48 |
| 2026-02-04 | 16.80 |
| 2026-02-03 | 16.57 |
| 2026-02-02 | 16.48 |
| 2026-01-30 | 16.60 |
| 2026-01-29 | 16.61 |
| 2026-01-28 | 16.80 |
| 2026-01-27 | 16.63 |
| 2026-01-26 | 17.06 |
| 2026-01-23 | 17.28 |
| 2026-01-22 | 17.45 |
| 2026-01-21 | 17.46 |
| 2026-01-20 | 17.35 |
| 2026-01-16 | 17.65 |
| 2026-01-15 | 18.05 |
| 2026-01-14 | 17.60 |
| 2026-01-13 | 17.61 |
| 2026-01-12 | 18.04 |
| 2026-01-09 | 18.07 |
| 2026-01-08 | 18.44 |